Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KRAS | P01116 | 1/20 | 0.37 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | DCTPP1 | Q9H773 | 1/20 | 0.32 |
| ▸ | MIF | P14174 | 1/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22945711 | 0.90 | KRAS (0.39) | KRASTGFBR1KDM4ENPC1ALDH1A1 | |
| SCHEMBL22944721 | 0.90 | KRAS (0.40) | KRASTGFBR1KDM4ENPC1ALDH1A1 | |
| SCHEMBL22945970 | 0.89 | KRAS (0.39) | KRASTGFBR1KDM4ENPC1ALDH1A1 | |
| SCHEMBL22945011 | 0.87 | KRAS (0.38) | KRASTGFBR1KDM4ENPC1ALDH1A1 | |
| SCHEMBL22944784 | 0.84 | KRAS (0.35) | KRASTGFBR1DCTPP1 | |
| SCHEMBL22945736 | 0.84 | — | — | |
| SCHEMBL21515279 | 0.84 | METAP1 (0.39) | TGFBR1KDM4ENPC1ALDH1A1TP53 | |
| SCHEMBL22945988 | 0.83 | — | — | |
| SCHEMBL22945982 | 0.83 | ALOX5 (0.31) | — | |
| SCHEMBL22945735 | 0.82 | KRAS (0.37) | KRASTGFBR1DCTPP1MIFGABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11812658-B2 | Compound and organic light emitting diode comprising same | LG CHEM, LTD. (KR) | 2023-11-07 | — | — | US | disclosed |
| US-11812658-B2 | Compound and organic light emitting diode comprising same | LG CHEM, LTD. (KR) | 2023-11-07 | — | — | US | disclosed |
| US-20210036236-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2021-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210036236-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | DRD1, DRD3, DRD2 | KRAS 1811/4885TGFBR1 519/4885KDM4E 1857/4885 |
| US-11812658-B2 | Compound and organic light emitting diode comprising same | DRD1, DRD3, DRD2 | KRAS 1811/4885TGFBR1 519/4885KDM4E 1857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.